Large-scale testing (Phase 3)Study completedNCT03059992
What this trial is testing
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
Who this might be right for
Invasive CandidiasisMucocutaneous CandidiasisCoccidioidomycosis+7 more
Scynexis, Inc. 233